7Baggers
 published on: 2025-10-02 19:35:14  newser.com Fri, 03 Oct 2025 00:35:14 GMT
 Published on: 2025-10-01 08:27:07  newser.com Wed, 01 Oct 2025 13:27:07 GMT
 Published on: 2025-09-30 03:08:07  newser.com Tue, 30 Sep 2025 08:08:07 GMT
 Published on: 2025-09-28 22:31:40  newser.com Mon, 29 Sep 2025 03:31:40 GMT
 akebia therapeutics (nasdaq:akba) cut to buy at wall street zen  MarketBeat Thu, 18 Sep 2025 04:27:07 GMT
 akebia at h.c. wainwright: strategic growth in anemia treatment  Investing.com Mon, 08 Sep 2025 07:00:00 GMT
 biotech movers: akebia soars on expanded partnership with otsuka  TheStreet Fri, 05 Sep 2025 18:23:08 GMT
 akebia at wells fargo conference: strategic growth in healthcare  Investing.com Thu, 04 Sep 2025 07:00:00 GMT
 biotech movers: akebia shares down after pricing stock offering  TheStreet Sat, 30 Aug 2025 18:04:26 GMT
 published on: 2025-08-29 11:27:47  Newser Fri, 29 Aug 2025 16:27:47 GMT
 published on: 2025-08-29 01:11:05  Newser Fri, 29 Aug 2025 06:11:05 GMT
 published on: 2025-08-28 18:24:19  Newser Thu, 28 Aug 2025 23:24:19 GMT
 published on: 2025-08-28 12:35:30  Newser Thu, 28 Aug 2025 17:35:30 GMT
 Akebia Therapeutics to Present at Upcoming Investor Conferences  Yahoo Finance Thu, 28 Aug 2025 07:00:00 GMT
 published on: 2025-08-26 12:34:55  Newser Tue, 26 Aug 2025 17:34:55 GMT
 published on: 2025-08-26 04:22:30  Newser Tue, 26 Aug 2025 09:22:30 GMT

Akebia Therapeutics, Inc
(NASDAQ:AKBA) 

AKBA stock logo

Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of renal therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the tre...

Full Time Employees: 358
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends